ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 723,88
-0,26%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. AVEO Pharmaceuticals Inc (AVEO)

  7. AVEO Pharmaceuticals Inc (AVEO) Actualités

AVEO

AVEO Pharmaceuticals (AVEO)

AVEO Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AVEO
DateHeureSourceTitreSymboleSociété
28/03/202420h22GlobeNewswire Inc.CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory CommitteeNASDAQ:AVEOAVEO Pharmaceuticals Inc
25/03/202413h10GlobeNewswire Inc.AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory CommitteeNASDAQ:AVEOAVEO Pharmaceuticals Inc
06/02/202414h10GlobeNewswire Inc.AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The OncologistNASDAQ:AVEOAVEO Pharmaceuticals Inc
16/01/202413h30GlobeNewswire Inc.AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)NASDAQ:AVEOAVEO Pharmaceuticals Inc
30/01/202322h08Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:AVEOAVEO Pharmaceuticals Inc
24/01/202312h07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202323h20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202323h05Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202322h47Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202322h44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AVEOAVEO Pharmaceuticals Inc
19/01/202322h35GlobeNewswire Inc.LG Chem Completes Acquisition of AVEO OncologyNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/01/202314h41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
23/12/202222h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
25/11/202214h09Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
15/11/202214h33Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
11/11/202223h37ValueWalkIs Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?NASDAQ:AVEOAVEO Pharmaceuticals Inc
10/11/202205h26TipRanksSVB Securities Sticks to Its Hold Rating for AVEO Pharma (AVEO)NASDAQ:AVEOAVEO Pharmaceuticals Inc
10/11/202205h16TipRanksAVEO Pharma (AVEO) Receives a Hold from Robert W. BairdNASDAQ:AVEOAVEO Pharmaceuticals Inc
07/11/202222h11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AVEOAVEO Pharmaceuticals Inc
01/11/202222h02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
28/10/202223h05TipRanksJonesTrading Reaffirms Their Hold Rating on AVEO Pharma (AVEO)NASDAQ:AVEOAVEO Pharmaceuticals Inc
24/10/202214h50TipRanksAnalysts Conflicted on These Healthcare Names: AVEO Pharma (AVEO) and HCA Healthcare (HCA)NASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202221h15Dow Jones NewsAVEO Pharma Shares Soar After LG Chem Takeover NewsNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202219h45TipRanksH.C. Wainwright downgrades AVEO Pharma (AVEO) to a HoldNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202213h54TipRanksAVEO Soars on LG Chem DealNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202213h35TipRanksJonesTrading Keeps Their Buy Rating on AVEO Pharma (AVEO)NASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202212h26Dow Jones NewsAVEO Pharmaceuticals Shares Soar on Takeover by LG ChemNASDAQ:AVEOAVEO Pharmaceuticals Inc
18/10/202212h05Dow Jones NewsLG Chem to Acquire AVEO Pharmaceuticals for $566 MillionNASDAQ:AVEOAVEO Pharmaceuticals Inc
14/10/202206h05TipRanksAVEO Pharma (AVEO) Gets a Buy from Robert W. BairdNASDAQ:AVEOAVEO Pharmaceuticals Inc
14/10/202205h55TipRanksAVEO Pharma (AVEO) Receives a Buy from SVB SecuritiesNASDAQ:AVEOAVEO Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:AVEO

Dernières Valeurs Consultées

EU
RNO
Renault
EU
HO
Thales
EU
PX1
CAC 40
USI
USTECH100
US Tech 100
EU
EN
Bouygues
EU
CAP
Capgemini
EU
BN
Danone
COIN
BTCUSD
Bitcoin
EU
VK
Vallourec
NYSE
MRK
Merck
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés